• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胱氨酸/半胱氨酸代谢调节三阴性乳腺癌的进展及对治疗的反应(综述)

Cystine/cysteine metabolism regulates the progression and response to treatment of triple‑negative breast cancer (Review).

作者信息

Xiao Wanting, Xu Chaoyang

机构信息

Department of Breast and Thyroid Surgery, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, Zhejiang 321000, P.R. China.

出版信息

Oncol Lett. 2024 Aug 30;28(5):521. doi: 10.3892/ol.2024.14654. eCollection 2024 Nov.

DOI:10.3892/ol.2024.14654
PMID:39268159
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11391256/
Abstract

Breast cancer is the most prevalent neoplasm affecting women globally, of which a notable proportion of cases are triple-negative breast cancer (TNBC). However, there are limited curative treatment options for patients with TNBC, despite advancements in the field. Amino acids and amino acid transporters serve vital roles in the regulation of tumor metabolism. Notably, cystine and cysteine can interconvert via a redox reaction, with cysteine exerting control on cell survival and growth and exogenous cystine serving a crucial role in the proliferation of numerous types of cancers. Breast cancer has been reported to disrupt the cystine/cysteine metabolism pathway, as cystine and cysteine transporters affect the development and growth of tumors. The present review aims to provide a comprehensive overview of the metabolic pathways involving cystine and cysteine in normal and TNBC cells. Furthermore, the roles of cystine and cysteine transporters in TNBC progression and metastasis and their potential as therapeutic targets for treatment of TNBC are evaluated.

摘要

乳腺癌是全球影响女性的最常见肿瘤,其中相当一部分病例为三阴性乳腺癌(TNBC)。然而,尽管该领域取得了进展,但TNBC患者的治愈性治疗选择仍然有限。氨基酸和氨基酸转运蛋白在肿瘤代谢调节中发挥着重要作用。值得注意的是,胱氨酸和半胱氨酸可通过氧化还原反应相互转化,半胱氨酸控制细胞存活和生长,而外源性胱氨酸在多种癌症的增殖中起关键作用。据报道,乳腺癌会破坏胱氨酸/半胱氨酸代谢途径,因为胱氨酸和半胱氨酸转运蛋白会影响肿瘤的发生和生长。本综述旨在全面概述正常细胞和TNBC细胞中涉及胱氨酸和半胱氨酸的代谢途径。此外,还评估了胱氨酸和半胱氨酸转运蛋白在TNBC进展和转移中的作用及其作为TNBC治疗靶点的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2df5/11391256/2441a9495444/ol-28-05-14654-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2df5/11391256/2afb3b71be8e/ol-28-05-14654-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2df5/11391256/2441a9495444/ol-28-05-14654-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2df5/11391256/2afb3b71be8e/ol-28-05-14654-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2df5/11391256/2441a9495444/ol-28-05-14654-g01.jpg

相似文献

1
Cystine/cysteine metabolism regulates the progression and response to treatment of triple‑negative breast cancer (Review).胱氨酸/半胱氨酸代谢调节三阴性乳腺癌的进展及对治疗的反应(综述)
Oncol Lett. 2024 Aug 30;28(5):521. doi: 10.3892/ol.2024.14654. eCollection 2024 Nov.
2
NRF2 activation by cysteine as a survival mechanism for triple-negative breast cancer cells.半胱氨酸对 NRF2 的激活作用是三阴性乳腺癌细胞的一种生存机制。
Oncogene. 2024 May;43(22):1701-1713. doi: 10.1038/s41388-024-03025-0. Epub 2024 Apr 10.
3
CHAC1 degradation of glutathione enhances cystine-starvation-induced necroptosis and ferroptosis in human triple negative breast cancer cells via the GCN2-eIF2α-ATF4 pathway.CHAC1对谷胱甘肽的降解通过GCN2-eIF2α-ATF4途径增强人三阴性乳腺癌细胞中胱氨酸饥饿诱导的坏死性凋亡和铁死亡。
Oncotarget. 2017 Dec 9;8(70):114588-114602. doi: 10.18632/oncotarget.23055. eCollection 2017 Dec 29.
4
Cystine addiction of triple-negative breast cancer associated with EMT augmented death signaling.三阴性乳腺癌的胱氨酸成瘾与上皮-间质转化增强的死亡信号相关。
Oncogene. 2017 Jul 27;36(30):4235-4242. doi: 10.1038/onc.2016.394. Epub 2016 Nov 21.
5
Functional interactions of the cystine/glutamate antiporter, CD44v and MUC1-C oncoprotein in triple-negative breast cancer cells.胱氨酸/谷氨酸反向转运体、CD44v和MUC1-C癌蛋白在三阴性乳腺癌细胞中的功能相互作用。
Oncotarget. 2016 Mar 15;7(11):11756-69. doi: 10.18632/oncotarget.7598.
6
Ferroptosis induction via targeting metabolic alterations in triple-negative breast cancer.通过靶向三阴性乳腺癌代谢改变诱导铁死亡。
Biomed Pharmacother. 2023 Dec 31;169:115866. doi: 10.1016/j.biopha.2023.115866. Epub 2023 Nov 10.
7
Biological insights in non-small cell lung cancer.非小细胞肺癌的生物学认识。
Cancer Biol Med. 2023 Jun 28;20(7):500-18. doi: 10.20892/j.issn.2095-3941.2023.0108.
8
A Cystine-Cysteine Intercellular Shuttle Prevents Ferroptosis in xCT Pancreatic Ductal Adenocarcinoma Cells.一种胱氨酸-半胱氨酸细胞间穿梭机制可防止xCT胰腺导管腺癌细胞发生铁死亡。
Cancers (Basel). 2021 Mar 21;13(6):1434. doi: 10.3390/cancers13061434.
9
NADPH debt drives redox bankruptcy: SLC7A11/xCT-mediated cystine uptake as a double-edged sword in cellular redox regulation.烟酰胺腺嘌呤二核苷酸磷酸(NADPH)亏空导致氧化还原失衡:溶质载体家族7成员11(SLC7A11)/胱氨酸-谷氨酸反向转运体(xCT)介导的胱氨酸摄取在细胞氧化还原调节中是一把双刃剑。
Genes Dis. 2020 Nov 25;8(6):731-745. doi: 10.1016/j.gendis.2020.11.010. eCollection 2021 Nov.
10
Lysosomal cystine governs ferroptosis sensitivity in cancer via cysteine stress response.溶酶体胱氨酸通过半胱氨酸应激反应来控制癌症中铁死亡的敏感性。
Mol Cell. 2023 Sep 21;83(18):3347-3359.e9. doi: 10.1016/j.molcel.2023.08.004. Epub 2023 Aug 29.

引用本文的文献

1
Penicilazaphilone C triggers ferroptosis in triple-negative breast cancer cells via the MDM2/p53/SLC7 A11/GPX4 pathway.青霉氮杂菲酮C通过MDM2/p53/SLC7A11/GPX4途径在三阴性乳腺癌细胞中引发铁死亡。
Discov Oncol. 2025 Jun 2;16(1):983. doi: 10.1007/s12672-025-02687-w.
2
Absence of Cysteine and Iron Chelation Induces Ferroptosis in Triple-Negative Breast Cancer Cells.半胱氨酸缺失和铁螯合诱导三阴性乳腺癌细胞发生铁死亡。
Breast Cancer (Auckl). 2025 Jan 16;19:11782234241311012. doi: 10.1177/11782234241311012. eCollection 2025.

本文引用的文献

1
Gankyrin inhibits ferroptosis through the p53/SLC7A11/GPX4 axis in triple-negative breast cancer cells.Gankyrin 通过 p53/SLC7A11/GPX4 轴抑制三阴性乳腺癌细胞中的铁死亡。
Sci Rep. 2023 Dec 8;13(1):21916. doi: 10.1038/s41598-023-49136-8.
2
Clinical Course and Mutational Analysis of Patients with Cystine Stone: A Single-Center Experience.胱氨酸结石患者的临床病程及突变分析:单中心经验
Biomedicines. 2023 Oct 11;11(10):2747. doi: 10.3390/biomedicines11102747.
3
Cystine/glutamate antiporter xCT deficiency reduces metastasis without impairing immune system function in breast cancer mouse models.
胱氨酸/谷氨酸反向转运蛋白 xCT 缺乏可减少乳腺癌小鼠模型的转移,而不损害免疫系统功能。
J Exp Clin Cancer Res. 2023 Sep 29;42(1):254. doi: 10.1186/s13046-023-02830-x.
4
Structural insights into FSP1 catalysis and ferroptosis inhibition.结构洞察 FSP1 催化和铁死亡抑制。
Nat Commun. 2023 Sep 22;14(1):5933. doi: 10.1038/s41467-023-41626-7.
5
Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy.病毒样颗粒 (VLP) 疫苗在癌症免疫治疗中的应用。
Int J Mol Sci. 2023 Aug 19;24(16):12963. doi: 10.3390/ijms241612963.
6
Dietary Manipulation of Amino Acids for Cancer Therapy.氨基酸饮食干预在癌症治疗中的应用
Nutrients. 2023 Jun 25;15(13):2879. doi: 10.3390/nu15132879.
7
Solute carrier-related signature for assessing prognosis and immunity in patients with clear-cell renal cell carcinoma.溶质载体相关标志物用于评估透明细胞肾细胞癌患者的预后和免疫状态。
Oncol Res. 2023 Apr 10;31(2):181-192. doi: 10.32604/or.2023.028051. eCollection 2023.
8
Immunotherapy against the Cystine/Glutamate Antiporter xCT Improves the Efficacy of APR-246 in Preclinical Breast Cancer Models.针对胱氨酸/谷氨酸反向转运体xCT的免疫疗法可提高APR-246在临床前乳腺癌模型中的疗效。
Biomedicines. 2022 Nov 8;10(11):2843. doi: 10.3390/biomedicines10112843.
9
Development of doxorubicin hydrochloride-loaded whey protein nanoparticles and its surface modification with N-acetyl cysteine for triple-negative breast cancer.盐酸多柔比星载乳清蛋白纳米粒的研制及其与 N-乙酰半胱氨酸的表面修饰用于三阴性乳腺癌。
Drug Deliv Transl Res. 2022 Dec;12(12):3047-3062. doi: 10.1007/s13346-022-01169-8. Epub 2022 Apr 30.
10
Transsulfuration, minor player or crucial for cysteine homeostasis in cancer.转硫作用:半胱氨酸在癌症中维持平衡的次要角色或关键因素。
Trends Cell Biol. 2022 Sep;32(9):800-814. doi: 10.1016/j.tcb.2022.02.009. Epub 2022 Mar 29.